Empirical Finance LLC Sells 151 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Empirical Finance LLC decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 11,955 shares of the medical equipment provider’s stock after selling 151 shares during the period. Empirical Finance LLC’s holdings in Intuitive Surgical were worth $6,240,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in ISRG. Private Advisory Group LLC bought a new position in Intuitive Surgical during the third quarter worth about $398,000. LVW Advisors LLC boosted its holdings in Intuitive Surgical by 8.3% during the third quarter. LVW Advisors LLC now owns 1,429 shares of the medical equipment provider’s stock worth $702,000 after buying an additional 109 shares during the last quarter. Hilltop Wealth Advisors LLC bought a new position in Intuitive Surgical during the third quarter worth about $866,000. Livforsakringsbolaget Skandia Omsesidigt boosted its holdings in Intuitive Surgical by 356.7% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 2,923 shares of the medical equipment provider’s stock worth $1,436,000 after buying an additional 2,283 shares during the last quarter. Finally, Valeo Financial Advisors LLC boosted its holdings in Intuitive Surgical by 13.2% during the third quarter. Valeo Financial Advisors LLC now owns 4,119 shares of the medical equipment provider’s stock worth $2,023,000 after buying an additional 480 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 0.9 %

NASDAQ:ISRG opened at $582.98 on Friday. The firm has a market capitalization of $207.65 billion, a price-to-earnings ratio of 90.95, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The stock’s 50 day moving average price is $554.85 and its two-hundred day moving average price is $513.96.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. Wells Fargo & Company raised their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Leerink Partners raised their target price on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Evercore ISI lifted their price objective on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Robert W. Baird lifted their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Finally, Royal Bank of Canada lifted their price objective on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Insiders Place Their Bets

In related news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 5,940 shares of company stock valued at $3,333,485 in the last 90 days. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.